Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced encouraging top-line results from a Phase 2a trial evaluating ATI-2138, its oral investigational treatment targeting moderate-to-severe atopic dermatitis (AD). The study …
Aclaris Reports Positive Phase 2a Results for ATI-2138 in Atopic Dermatitis Trial Read More
WASHINGTON, D.C. — In a decisive shift in federal vaccine policy, U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. has formally adopted a recommendation from the Centers for …
U.S. Bans Mercury in Flu Vaccines, Marking End to Thimerosal Use in American Immunization Read More
JENNERSVILLE, PA — A long-awaited milestone was reached Friday as state and local leaders joined ChristianaCare officials for the ribbon-cutting of a new hospital and emergency room in Jennersville, marking …
Emergency Care Returns to Southern Chester County with Opening of New Jennersville Hospital Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration on Friday placed Sarepta Therapeutics’ gene therapy trials for limb girdle muscular dystrophy on clinical hold following the deaths of three patients …
FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure Read More
WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has unveiled a groundbreaking initiative aimed at expanding access to potentially curative gene therapies for individuals with sickle cell …
Medicaid to Expand Access to Life-Changing Gene Therapy for Sickle Cell Patients in 33 States Read More
WASHINGTON, D.C. — Federal health authorities are investigating a multistate Salmonella outbreak linked to frozen sprouted beans sold under the Deep brand, prompting an urgent recall and public health warning. As …
Frozen Sprouted Beans Recalled Nationwide After Salmonella Outbreak Hospitalizes Four Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced that the first patient has been dosed in its Phase 2/3 GARDian3 clinical trial evaluating OCU410ST, a gene therapy candidate designed …
Ocugen Doses First Patient in Pivotal Trial for Stargardt Gene Therapy Read More
MALVERN, PA — In a major scientific advance, Progenra Inc. has announced the discovery of a novel class of small-molecule drugs designed to restore the function of mutant forms of …
Progenra Breakthrough Offers New Hope for Parkinson’s Disease and Beyond Read More
WASHINGTON, D.C. — In a groundbreaking effort to revolutionize brain repair, the Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services (HHS), …
ARPA-H Launches Ambitious Program to Regenerate Brain Tissue and Restore Neurological Function Read More
PLYMOUTH MEETING, PA — New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer. …
Study Finds Most Prostate Cancer Patients Following NCCN Guidelines Live Long, Healthy Lives Read More